My guest for this episode is Dr. Ashkan Ehdaie, an Electrophysiologist at Cedars-Sinai Medical Center in Los Angeles. Dr. Ehdaie is currently an Assistant Professor of Cardiology and Associate Director of the Clinical Cardiac Electrophysiology Fellowship Training Program.

I interview Dr. Ehdaie about the different types of Vtach, the risks and outcomes associated with treating each type, and we dig into some of the protocols used for various scenarios where Vtach requires treatment, both medically and surgically. 

All Things Afib is hosted by me, Dr. Armin Kiankhooy. As a board-certified cardiothoracic surgeon, my focus is on advanced treatments for heart and lung failure and minimally-invasive surgical treatments for atrial fibrillation such as the Hybrid Maze procedure. You can find me on staff at Adventist Health Heart and Vascular Institute in St. Helena California.

Discussion points:

How is Vtach different from supraventricular tachycardia?

What are the different types of Vtach?

What is the conversation when a patient is diagnosed with Idiopathic Vtach?

Where is the threshold between treating with meds or ablation?

Why does malignant Vtach occur?

Monomorphic vs. polymorphic

The medications that can cause polymorphic Vtach

Patient follow up procedures and the LifeVest

We do imaging for Afib at a certain time post-procedure, when do you do it for Vtach?

What is the success rate when treating with ablation?

How much Vtach is too much?

A study focusing on reviving tissue, instead of destroying it with ablation

What else should our listeners know? “That Vtach is not one-dimensional, it has many presentations and complications.”

Resources:

Dr. Ashkan Ehdaie Cedars-Sinai

Dr. Ashkan Ehdaie LinkedIn

Dr. Kiankhooy LinkedIn

All Things AFib Website 

All Things AFib Twitter

All Things AFib YouTube Channel